Search research articles
Contact Us
Filters
Showing results (341-350 of 512) with videos related to
Page
of 52
Sort By:
The Lancet. Oncology
|
November 1, 2019
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial
Alice T Shaw, Benjamin J Solomon, Rita Chiari, et al.
Autoimmunity Reviews
|
January 10, 2020
Systemic lupus erythematosus associated with thymoma: A fifteen-year observational study in France
Nicolas Noël, Audrey Le Roy, Arnaud Hot, et al.
Nature Reviews. Clinical Oncology
|
March 15, 2025
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
Sophie M Ernst, Mihaela Aldea, Jan H von der Thüsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies
Francesco Facchinetti, Yohann Loriot, Floriane Brayé, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 2, 2010
A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung
Natasha B Leighl, Luis E Raez, Benjamin Besse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE
Marie Wislez, Fabrice Barlesi, Benjamin Besse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 28, 2023
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer
Clara Helal, Cédric Pobel, Arnaud Bayle, et al.
ERJ Open Research
|
February 17, 2018
Real-life experience of ceritinib in crizotinib-pretreated <i>ALK</i><sup>+</sup> advanced non-small cell lung cancer patients
Jacques Cadranel, Alexis B Cortot, Hervé Lena, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2021
Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities
Samia Hajem, Stéphane Ederhy, Stéphane Champiat, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 21, 2019
Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases
Ronan Flippot, Pamela Biondani, Edouard Auclin, et al.
Page
of 52
Search research articles
Search
Showing results (341-350 of 512) with videos related to
Sort By:
Page
of 52
The Lancet. Oncology
|
November 1, 2019
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial
Alice T Shaw, Benjamin J Solomon, Rita Chiari, et al.
Autoimmunity Reviews
|
January 10, 2020
Systemic lupus erythematosus associated with thymoma: A fifteen-year observational study in France
Nicolas Noël, Audrey Le Roy, Arnaud Hot, et al.
Nature Reviews. Clinical Oncology
|
March 15, 2025
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
Sophie M Ernst, Mihaela Aldea, Jan H von der Thüsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies
Francesco Facchinetti, Yohann Loriot, Floriane Brayé, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 2, 2010
A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung
Natasha B Leighl, Luis E Raez, Benjamin Besse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 19, 2014
Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE
Marie Wislez, Fabrice Barlesi, Benjamin Besse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 28, 2023
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer
Clara Helal, Cédric Pobel, Arnaud Bayle, et al.
ERJ Open Research
|
February 17, 2018
Real-life experience of ceritinib in crizotinib-pretreated <i>ALK</i><sup>+</sup> advanced non-small cell lung cancer patients
Jacques Cadranel, Alexis B Cortot, Hervé Lena, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2021
Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities
Samia Hajem, Stéphane Ederhy, Stéphane Champiat, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 21, 2019
Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases
Ronan Flippot, Pamela Biondani, Edouard Auclin, et al.
Page
of 52